<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id><journal-id journal-id-type="publisher-id">BMRI</journal-id><journal-title-group><journal-title>BioMed Research International</journal-title></journal-title-group><issn pub-type="ppub">2314-6133</issn><issn pub-type="epub">2314-6141</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24527444</article-id><article-id pub-id-type="pmc">3909970</article-id><article-id pub-id-type="doi">10.1155/2014/360936</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>The Comparison of the Effects of Sevoflurane Inhalation Anesthesia and Intravenous Propofol Anesthesia on Oxidative Stress in One Lung Ventilation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Erturk</surname><given-names>Engin</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Topaloglu</surname><given-names>Selma</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dohman</surname><given-names>Davut</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kutanis</surname><given-names>Dilek</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Be&#x0015f;ir</surname><given-names>Ahmet</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Demirci</surname><given-names>Yucel</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kayir</surname><given-names>Selcuk</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mentese</surname><given-names>Ahmet</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Anesthesiology and Intensive Care, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey</aff><aff id="I2"><sup>2</sup>Department of Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey</aff><author-notes><corresp id="cor1">*Engin Erturk: <email>engin_md@yahoo.com</email></corresp><fn fn-type="other"><p>Academic Editor: Ahmet Eroglu</p></fn></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>5</day><month>1</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>360936</elocation-id><history><date date-type="received"><day>30</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Engin Erturk et al.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background</italic>. The aim of this study is to compare the effects of sevoflurane and propofol on one lung ventilation (OLV) induced ischemia-reperfusion injury (IRI) by determining the blood gas, ischemia-modified albumin (IMA), and malonyldialdehyde (MDA). <italic>Material and Methods</italic>. Forty-four patients undergoing thoracic surgery with OLV were randomized in two groups (sevoflurane Group S, propofol Group P). Anesthesia was inducted with thiopental and was maintained with 1&#x02013;2.5% of sevoflurane within the 40/60% of O<sub>2</sub>/N<sub>2</sub>O mixture in Group S. In Group P anesthesia was inducted with propofol and was maintained with infusion of propofol and remifentanil. Hemodynamic records and blood samples were obtained before anesthesia induction (<italic>t</italic>
<sub>1</sub>), 1&#x02009;min before two lung ventilation (<italic>t</italic>
<sub>2</sub>), 30&#x02009;min after two lung ventilation (<italic>t</italic>
<sub>3</sub>), and postoperative sixth hours (<italic>t</italic>
<sub>4</sub>). <italic>Results</italic>. Heart rate at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> in Group P was significantly lower than that in Group S. While there were no significant differences in terms of pH and pCO<sub>2</sub>, pO<sub>2</sub> at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> in Group S was significantly lower than that in Group P. IMA levels at <italic>t</italic>
<sub>4</sub> in Group S were significantly lower than those in Group P. <italic>Conclusion</italic>. Sevoflurane may offer protection against IRI after OLV in thoracic surgery.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>One-lung ventilation (OLV) is usually performed to provide wide surgical area in thoracic surgery. During the OLV hypoxic pulmonary vasoconstriction occurs in nonventilated lung (NVL). While the blood flow of other lobe increases, perfusion and oxygenation of NVL decrease. As a result of this, tissue ischemia occurs in nonventilated site. After resuming two-lung ventilation (2LV), the reperfusion of the blood and reentry of oxygen to ischemic tissue cause sudden and significant increase in reactive oxygen species (ROS) production [<xref rid="B1" ref-type="bibr">1</xref>]. Increased ROS induce lipid peroxidation of polyunsaturated fatty acid in biological membranes and plasma lipoproteins [<xref rid="B2" ref-type="bibr">2</xref>]. These events, reentry of the oxygen to ischemic tissue and peroxidative reaction of some biological structure, are called ischemia-reperfusion injury (IRI). IRI may cause some cardiac complications [<xref rid="B3" ref-type="bibr">3</xref>].</p><p>The total antioxidant status (TAS) of human body counteracts oxidative stress. Resuming the 2LV from OLV or after treatment of pneumothorax [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>] hydrostatic pressure rises may cause increase in alveolocapillary membrane permeability leading to pulmonary oedema. Bowler et al. reported that TAS was decreased by pulmonary edema fluids in acute lung injuries [<xref rid="B6" ref-type="bibr">6</xref>]. It was stated that after 2LV severe oxidative injuries may be important in patients without adequate TAS [<xref rid="B1" ref-type="bibr">1</xref>].</p><p>There are a lot of studies carried out to prevent IRI [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>]. Some antioxidant agents can restrain lipid peroxidation and reperfusion injury. Propofol, chemically similar to phenol based free radical scavengers, was used for this purpose [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>]. On the other hand some studies emphasized that halogenated inhalation agent, sevoflurane, can lead to reduction in IRI [<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>].</p><p>After reperfusion of ischemic tissue malonyldialdehyde (MDA), toxic intermediate product of lipid peroxidation and ischemia-modified albumin (IMA) levels increase in blood. Thus both MDA and IMA were used as a marker of IRI studies [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B9" ref-type="bibr">9</xref>].</p><p>The aim of this randomized, prospective, double-blind study is to compare the effects of propofol and sevoflurane on IRI in patients undergoing thoracic surgery in which OLV/2LV was used. MDA, IMA, blood gas levels, and hemodynamics were measured for this purpose.</p></sec><sec id="sec2"><title>2. Material and Methods</title><p>After obtaining the ethics committee approval and patient informed consent the study was carried out in 44 patients, aged between 18 and 65, ASA physical status I or II, undergoing OLV/2LV for thoracic surgery. Sealed envelope method was used for randomization and the patients were divided into two groups (sevoflurane: Group S, <italic>n</italic> = 22 and propofol: Group P, <italic>n</italic> = 22). Patients with ASA score of III or more and severe metabolic, renal, or hepatic diseases, using cigarettes or antioxidant agents, were excluded from the study.</p><p>All patients were sedated with 3&#x02009;mg of midazolam intramuscularly 30&#x02009;min before the operation. In the operating room, electrocardiography, peripheral arterial oxygen saturation, and invasive arterial blood pressure were monitored. First blood samples for blood gas, MDA, and IMA were obtained and vital parameters were recorded at this time (<italic>t</italic>
<sub>1</sub>). Thiopental (6&#x02009;mg/kg) in Group S and propofol (1.5&#x02013;2.5&#x02009;mg/kg) in Group P were used for induction of anesthesia. After the administration of fentanil 2&#x02009;<italic>&#x003bc;</italic>/kg and rocuronium 0.6&#x02009;mg/kg all patients were intubated with double lumen tubes. In Group S anesthesia was maintained with 1&#x02013;2.5% of sevoflurane within the 40/60% of O<sub>2</sub>/N<sub>2</sub>O mixture. In Group P anesthesia was maintained with total intravenous anesthesia using infusion of 125&#x02013;250&#x02009;<italic>&#x003bc;</italic>/kg/min of propofol and 0.1&#x02013;0.25&#x02009;<italic>&#x003bc;</italic>/kg/min of remifentanil. Ventilation was mechanically controlled and OLV was put into practice for surgical intervention using tidal volume: 6&#x02013;8&#x02009;mL/kg, with respiratory rate: 12&#x02013;20 and fraction of inspired O<sub>2</sub>: 1 adjusted to CO<sub>2</sub>: 35&#x02013;45&#x02009;mmHg. After the required procedure was carried out 2LV was resumed from OLV. The blood samples were obtained 1&#x02009;min before 2LV (<italic>t</italic>
<sub>2</sub>) and 30&#x02009;min after 2LV (<italic>t</italic>
<sub>3</sub>). Hemodynamics was also recorded at these intervals. At the end of the operation patients were extubated and transferred to Surgical Intensive Care Unit. Last blood samples and hemodynamic record were obtained at postoperative sixth hour (<italic>t</italic>
<sub>4</sub>).</p><p>The Kolmogorov-Smirnov test was used to determine normality and homogeneity of data distribution. Parametric data (age, blood pressure, OLV time) were compared using one-way analysis of variation (ANOVA). Nonparametric data were compared using the Kruskal-Wallis test. MDA, IMA, and blood gas analysis were compared using Student's <italic>t</italic>-test between two groups.</p></sec><sec id="sec3"><title>3. Results</title><p>There were no significant differences between the groups with respect to age, sex, and OLV time (<xref ref-type="table" rid="tab1">Table 1</xref>).</p><p>Although there were no significant differences between the mean arterial pressures, heart rate at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> in Group P was significantly lower than the parameters in Group S (<italic>t</italic>
<sub>2</sub>; 65.05 &#x000b1; 11.32, 73.95 &#x000b1; 13.00, <italic>t</italic>
<sub>3</sub>; 62.91 &#x000b1; 12.21, 72.05 &#x000b1; 15.57, resp.) (<italic>P</italic> &#x0003c; 0.05) (<xref ref-type="table" rid="tab2">Table 2</xref>).</p><p>In blood gas analyses, there were no significant differences in terms of pH and pCO<sub>2</sub>. In Group S, pO<sub>2</sub> at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> was significantly lower than Group P (<italic>t</italic>
<sub>2</sub>: 151.45 &#x000b1; 71.85, 240.17 &#x000b1; 117.43, <italic>t</italic>
<sub>3</sub>: 186.55 &#x000b1; 67.62, 259.51 &#x000b1; 102.98, resp.) (<italic>P</italic> &#x0003c; 0.01) (<xref ref-type="table" rid="tab2">Table 2</xref>).</p><p>There were no significant differences between the groups in terms of MDA (<xref ref-type="fig" rid="fig1">Figure 1</xref>). IMA levels at <italic>t</italic>
<sub>4</sub> in Group S were significantly lower than Group P (0.76 &#x000b1; 0.09, 0.83 &#x000b1; 0.09, resp., <italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="sec4"><title>4. Discussion</title><p>This study showed that sevoflurane seemed to provide more protection than propofol by lower increasing in IMA and MDA. These findings have also been clinically important even if there were no complications in patients, because our patients were of ASA I or II score. If this study was performed with ASA III or more scored patients, cardiac or pulmonary complications due to lipid membrane peroxidation could occurr.</p><p>Cheng et al. [<xref rid="B1" ref-type="bibr">1</xref>] studied the effect of OLV on oxidative stress by measuring ROS and TAS in patients undergoing thoracic surgery with OLV. Their study showed that while ROS increases TAS decreases. In addition authors stated that extravascular lung fluid and intrathoracic blood volume were increased after 2LV. However, mostly patients do not counteract severe complication despite increasing ROS. They explained this condition by the fact that patients with normal TAS can tolerate these negative effects of oxidative stress. However, some critically ill [<xref rid="B15" ref-type="bibr">15</xref>], older aged [<xref rid="B16" ref-type="bibr">16</xref>], traumatic, or cancer patients have decreased TAS in their plasma. In these patients oxidative stress may cause destruction to DNA and protein and lipid structures.</p><p>Propofol was used to decrease IRI in a lot of clinical or experimental reperfusion studies. In an experimental reperfusion model, Akyol et al. [<xref rid="B2" ref-type="bibr">2</xref>] found that propofol was effective in protecting lung injury caused by increased oxidative stress and neutrophil accumulation. Huang et al. [<xref rid="B8" ref-type="bibr">8</xref>] investigated the effect of propofol infusion anesthesia on reperfusion injury compared to isoflurane inhalational anesthesia during OLV in thoracic surgery. They studied ROS and TAS and stated that propofol infusion shortens and attenuates oxidative stress during OLV. This protective effect of propofol was attributed to its antioxidant properties. However, they also stated that in critically ill patients, the use of total intravenous anesthesia with propofol infusion may be limited because of their unstable hemodynamics. Limited usage of propofol for this reason brings up different agent to prevent IRI.</p><p>The effects of inhalational anesthetics on ischemic myocardium have been investigated for many years. The protective effects of halogenated inhalational anesthetics were shown by different studies. Zaugg et al. [<xref rid="B17" ref-type="bibr">17</xref>] stated that inhalational anesthetics (sevoflurane and isoflurane) provide protection to IRI in cardiomyocytes by selectively priming K<sub>ATP</sub> channels through multiple triggering protein kinase C-coupled signaling pathways. In another study, Novalija et al. [<xref rid="B18" ref-type="bibr">18</xref>] showed that anesthetic preconditioning with sevoflurane improved adenosine triphosphate synthesis and reduced ROS formation in mitochondria after ischemia by a redox dependent mechanism. One of the good IRI models is cardiac surgery in which reperfusion may cause deterioration of rhythm and contraction of myocardium. Garcia et al. [<xref rid="B19" ref-type="bibr">19</xref>] stated at the end of their study that pharmacological preconditioning by sevoflurane provided protective role in cardiac events in coronary bypass patients.</p><p>Although there are a lot of studies in different ischemia-reperfusion models, there is no study in which the effect of sevoflurane on IRI was compared with propofol in OLV. Annecke et al. [<xref rid="B12" ref-type="bibr">12</xref>] compared the effects of sevoflurane on IRI with propofol after thoracic aortic occlusion in pig. After removing the clamp severe shock occurred in both study groups. While norepinephrine requirements in the sevoflurane group were significantly reduced during reperfusion, serum lactate dehydrogenase, aspartate transaminase, and alanine aminotransferase were also lower with sevoflurane. They state that the use of sevoflurane compared with propofol attenuated the hemodynamic sequelae of reperfusion injury in their model.</p><p>Another explanation of protective effect of sevoflurane against IRI may be the effect of it on hypoxic pulmonary vasoconstriction (HPV). During OLV while the perfusion of nonventilated lung is decreased, other lung's is increase. Nonventilated lung remains not only atelectatic, but also hypoperfused and ischemic. While inhalational anesthetics, sevoflurane, can inhibit HPV, intravenous anesthetics, propofol, are unaffected on HPV. Thus, nonventilated lung does not remain severely hypoperfused, and reperfusion injury was limited in patients with sevoflurane anesthesia. Lower pO<sub>2</sub> levels in Group S at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> show continuing of the perfusion of nonventilated/atelectatic lung in our patients.</p><p>IMA reaches a peak level of sixth hour of reperfusion and begins to decrease at twelfth hour. In this study, lower IMA level in Group S than Group P at postoperative sixth hour showed that sevoflurane provided protection against IRI. However, we did not show the protection with MDA level. There were no different MDA levels between the groups at all measurement times. Cheng et al. [<xref rid="B1" ref-type="bibr">1</xref>] stated that resection of lung cancer can decrease MDA levels. Some patients in both groups were operated on for lung cancer. Probably, we cannot support our findings with MDA.</p><p>Although these findings encourage us to use sevoflurane to provide protection against IRI, there were limitations in our study. The last blood sample was obtained at postoperative sixth hour. If we investigate postoperative twelfth hour or later, we can show the earlier return to normal IMA level in sevoflurane group. Another limitation of our study is the lacking of another control group. If another control group was formed with an agent with no protection to IRI, the study could be more powerful.</p><p>In conclusion we consider that sevoflurane may offer protection against reperfusion injury after one-lung ventilation in thoracic surgery.</p></sec></body><back><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y-J</given-names></name><name><surname>Chan</surname><given-names>K-C</given-names></name><name><surname>Chien</surname><given-names>C-T</given-names></name><name><surname>Sun</surname><given-names>W-Z</given-names></name><name><surname>Lin</surname><given-names>C-J</given-names></name></person-group><article-title>Oxidative stress during 1-lung ventilation</article-title><source><italic>Journal of Thoracic and Cardiovascular Surgery</italic></source><year>2006</year><volume>132</volume><issue>3</issue><fpage>513</fpage><lpage>518</lpage><pub-id pub-id-type="other">2-s2.0-33747787404</pub-id><pub-id pub-id-type="pmid">16935103</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akyol</surname><given-names>A</given-names></name><name><surname>Ulusoy</surname><given-names>H</given-names></name><name><surname>Imamo&#x0011f;lu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Does propofol or caffeic acid phenethyl ester prevent lung injury after hindlimb ischaemia-reperfusion in ventilated rats?</article-title><source><italic>Injury</italic></source><year>2006</year><volume>37</volume><issue>5</issue><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="other">2-s2.0-33646184223</pub-id><pub-id pub-id-type="pmid">16513122</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oxman</surname><given-names>T</given-names></name><name><surname>Arad</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Avazov</surname><given-names>N</given-names></name><name><surname>Rabinowitz</surname><given-names>B</given-names></name></person-group><article-title>Limb ischemia preconditions the heart against reperfusion tachyarrhythmia</article-title><source><italic>American Journal of Physiology: Heart and Circulatory Physiology</italic></source><year>1997</year><volume>273</volume><issue>4</issue><fpage>H1707</fpage><lpage>H1712</lpage><pub-id pub-id-type="other">2-s2.0-0030697307</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzpatrick</surname><given-names>S</given-names></name><name><surname>Acheson</surname><given-names>J</given-names></name><name><surname>Curran</surname><given-names>P</given-names></name></person-group><article-title>Re-expansion pulmonary oedema and circulatory shock in a 20-year-old man</article-title><source><italic>European Journal of Emergency Medicine</italic></source><year>2003</year><volume>10</volume><issue>2</issue><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="other">2-s2.0-0141544965</pub-id><pub-id pub-id-type="pmid">12789075</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misthos</surname><given-names>P</given-names></name><name><surname>Katsaragakis</surname><given-names>S</given-names></name><name><surname>Milingos</surname><given-names>N</given-names></name><etal/></person-group><article-title>Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation</article-title><source><italic>European Journal of Cardio-Thoracic Surgery</italic></source><year>2005</year><volume>27</volume><issue>3</issue><fpage>379</fpage><lpage>383</lpage><pub-id pub-id-type="other">2-s2.0-14644414146</pub-id><pub-id pub-id-type="pmid">15740942</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowler</surname><given-names>RP</given-names></name><name><surname>Velsor</surname><given-names>LW</given-names></name><name><surname>Duda</surname><given-names>B</given-names></name><etal/></person-group><article-title>Pulmonary edema fluid antioxidants are depressed in acute lung injury</article-title><source><italic>Critical Care Medicine</italic></source><year>2003</year><volume>31</volume><issue>9</issue><fpage>2309</fpage><lpage>2315</lpage><pub-id pub-id-type="other">2-s2.0-0042832198</pub-id><pub-id pub-id-type="pmid">14501961</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>R</given-names></name><name><surname>Yagmurdur</surname><given-names>H</given-names></name><name><surname>Kavutcu</surname><given-names>M</given-names></name><name><surname>Dikmen</surname><given-names>B</given-names></name></person-group><article-title>Propofol and tourniquet induced ischaemia reperfusion injury in lower extremity operations</article-title><source><italic>European Journal of Anaesthesiology</italic></source><year>2007</year><volume>24</volume><issue>2</issue><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="other">2-s2.0-33846046390</pub-id><pub-id pub-id-type="pmid">16938161</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C-H</given-names></name><name><surname>Wang</surname><given-names>Y-P</given-names></name><name><surname>Wu</surname><given-names>P-Y</given-names></name><name><surname>Chien</surname><given-names>C-T</given-names></name><name><surname>Cheng</surname><given-names>Y-J</given-names></name></person-group><article-title>Propofol infusion shortens and attenuates oxidative stress during one lung ventilation</article-title><source><italic>Acta Anaesthesiologica Taiwanica</italic></source><year>2008</year><volume>46</volume><issue>4</issue><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="other">2-s2.0-59149104074</pub-id><pub-id pub-id-type="pmid">19097962</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erturk</surname><given-names>E</given-names></name><name><surname>Cekic</surname><given-names>B</given-names></name><name><surname>Geze</surname><given-names>S</given-names></name><etal/></person-group><article-title>Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia-reperfusion injury</article-title><source><italic>European Journal of Anaesthesiology</italic></source><year>2009</year><volume>26</volume><issue>4</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="other">2-s2.0-68849105411</pub-id><pub-id pub-id-type="pmid">19401659</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahraman</surname><given-names>S</given-names></name><name><surname>Kilin&#x000e7;</surname><given-names>K</given-names></name><name><surname>Dal</surname><given-names>D</given-names></name><name><surname>Erdem</surname><given-names>K</given-names></name></person-group><article-title>Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury</article-title><source><italic>British Journal of Anaesthesia</italic></source><year>1997</year><volume>78</volume><issue>3</issue><fpage>279</fpage><lpage>281</lpage><pub-id pub-id-type="other">2-s2.0-0031046358</pub-id><pub-id pub-id-type="pmid">9135305</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y-J</given-names></name><name><surname>Wang</surname><given-names>Y-P</given-names></name><name><surname>Chien</surname><given-names>C-T</given-names></name><name><surname>Chen</surname><given-names>C-F</given-names></name></person-group><article-title>Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia</article-title><source><italic>Anesthesia and Analgesia</italic></source><year>2002</year><volume>94</volume><issue>6</issue><fpage>1617</fpage><lpage>1620</lpage><pub-id pub-id-type="other">2-s2.0-0036262185</pub-id><pub-id pub-id-type="pmid">12032039</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annecke</surname><given-names>T</given-names></name><name><surname>Kubitz</surname><given-names>JC</given-names></name><name><surname>Kahr</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of sevoflurane and propofol on ischaemia-reperfusion injury after thoracic-aortic occlusion in pigs</article-title><source><italic>British Journal of Anaesthesia</italic></source><year>2007</year><volume>98</volume><issue>5</issue><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="other">2-s2.0-34250358276</pub-id><pub-id pub-id-type="pmid">17371775</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carles</surname><given-names>M</given-names></name><name><surname>Dellamonica</surname><given-names>J</given-names></name><name><surname>Roux</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia-reperfusion</article-title><source><italic>British Journal of Anaesthesia</italic></source><year>2008</year><volume>100</volume><issue>1</issue><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="other">2-s2.0-38449103539</pub-id><pub-id pub-id-type="pmid">18029344</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conzen</surname><given-names>PF</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Detter</surname><given-names>C</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name></person-group><article-title>Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery</article-title><source><italic>Anesthesiology</italic></source><year>2003</year><volume>99</volume><issue>4</issue><fpage>826</fpage><lpage>833</lpage><pub-id pub-id-type="other">2-s2.0-0141655177</pub-id><pub-id pub-id-type="pmid">14508313</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsoulis</surname><given-names>K</given-names></name><name><surname>Kontakiotis</surname><given-names>T</given-names></name><name><surname>Leonardopoulos</surname><given-names>I</given-names></name><name><surname>Kotsovili</surname><given-names>A</given-names></name><name><surname>Legakis</surname><given-names>IN</given-names></name><name><surname>Patakas</surname><given-names>D</given-names></name></person-group><article-title>Serum total antioxidant status in severe exacerbation of asthma: correlation with the severity of the disease</article-title><source><italic>Journal of Asthma</italic></source><year>2003</year><volume>40</volume><issue>8</issue><fpage>847</fpage><lpage>854</lpage><pub-id pub-id-type="other">2-s2.0-0347986788</pub-id><pub-id pub-id-type="pmid">14736084</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Fujimoto</surname><given-names>K</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name></person-group><article-title>Age-related change of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide levels in normal human red blood cells</article-title><source><italic>Mechanisms of Ageing and Development</italic></source><year>1996</year><volume>86</volume><issue>3</issue><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="other">2-s2.0-0029914963</pub-id><pub-id pub-id-type="pmid">8733109</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaugg</surname><given-names>M</given-names></name><name><surname>Lucchinetti</surname><given-names>E</given-names></name><name><surname>Spahn</surname><given-names>DR</given-names></name><name><surname>Pasch</surname><given-names>T</given-names></name><name><surname>Schaub</surname><given-names>MC</given-names></name></person-group><article-title>Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial KATP channels via multiple signaling pathways</article-title><source><italic>Anesthesiology</italic></source><year>2002</year><volume>97</volume><issue>1</issue><fpage>4</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-0036308251</pub-id><pub-id pub-id-type="pmid">12131097</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novalija</surname><given-names>E</given-names></name><name><surname>Kevin</surname><given-names>LG</given-names></name><name><surname>Eells</surname><given-names>JT</given-names></name><name><surname>Henry</surname><given-names>MM</given-names></name><name><surname>Stowe</surname><given-names>DF</given-names></name></person-group><article-title>Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism</article-title><source><italic>Anesthesiology</italic></source><year>2003</year><volume>98</volume><issue>5</issue><fpage>1155</fpage><lpage>1163</lpage><pub-id pub-id-type="other">2-s2.0-0037406779</pub-id><pub-id pub-id-type="pmid">12717137</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>C</given-names></name><name><surname>Julier</surname><given-names>K</given-names></name><name><surname>Bestmann</surname><given-names>L</given-names></name><etal/></person-group><article-title>Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery</article-title><source><italic>British Journal of Anaesthesia</italic></source><year>2005</year><volume>94</volume><issue>2</issue><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="other">2-s2.0-13444251310</pub-id><pub-id pub-id-type="pmid">15556966</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Plasma concentration of malonyldialdehyde (<italic>P</italic> &#x0003e; 0.05).</p></caption><graphic xlink:href="BMRI2014-360936.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Plasma concentration of ischemia-modified albumin. IMA at <italic>t</italic>
<sub>4</sub> in Group S compared with Group P (*<italic>P</italic> &#x0003c; 0.05). ABSU: absorbance unit.</p></caption><graphic xlink:href="BMRI2014-360936.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients characteristic data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Group S</th><th align="center" rowspan="1" colspan="1">Group P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">52.31 &#x000b1; 13.22</td><td align="center" rowspan="1" colspan="1">52.45 &#x000b1; 11.80</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (M/F)</td><td align="center" rowspan="1" colspan="1">6/16</td><td align="center" rowspan="1" colspan="1">8/14</td></tr><tr><td align="left" rowspan="1" colspan="1">OLV time (min)</td><td align="center" rowspan="1" colspan="1">111.59 &#x000b1; 44.891</td><td align="center" rowspan="1" colspan="1">135.68 &#x000b1; 45.021</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Heart rate (HR), mean arterial pressure (MAP), and blood gases.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">
<italic>t</italic>
<sub>1</sub>
</th><th align="center" rowspan="1" colspan="1">
<italic>t</italic>
<sub>2</sub>
</th><th align="center" rowspan="1" colspan="1">
<italic>t</italic>
<sub>3</sub>
</th><th align="center" rowspan="1" colspan="1">
<italic>t</italic>
<sub>4</sub>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Group S</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;HR</td><td align="center" rowspan="1" colspan="1">81.77 &#x000b1; 12.78</td><td align="center" rowspan="1" colspan="1">73.95 &#x000b1; 13.00</td><td align="center" rowspan="1" colspan="1">72.05 &#x000b1; 15.57</td><td align="center" rowspan="1" colspan="1">79.27 &#x000b1; 13.93</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MAP</td><td align="center" rowspan="1" colspan="1">90.41 &#x000b1; 15.00</td><td align="center" rowspan="1" colspan="1">76.05 &#x000b1; 9.44</td><td align="center" rowspan="1" colspan="1">80.64 &#x000b1; 14.31</td><td align="center" rowspan="1" colspan="1">84.91 &#x000b1; 17.84</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pH</td><td align="center" rowspan="1" colspan="1">7.37 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">257.31 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">7.31 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">7.36 &#x000b1; 0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pO<sub>2</sub>
</td><td align="center" rowspan="1" colspan="1">154.95 &#x000b1; 92.03</td><td align="center" rowspan="1" colspan="1">151.45 &#x000b1; 71.85*</td><td align="center" rowspan="1" colspan="1">186.55 &#x000b1; 67.62*</td><td align="center" rowspan="1" colspan="1">147.43 &#x000b1; 71.41</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pCO<sub>2</sub>
</td><td align="center" rowspan="1" colspan="1">44.35 &#x000b1; 6.75</td><td align="center" rowspan="1" colspan="1">45.01 &#x000b1; 8.09</td><td align="center" rowspan="1" colspan="1">45.15 &#x000b1; 7.6</td><td align="center" rowspan="1" colspan="1">39.88 &#x000b1; 5.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Group P</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;HR</td><td align="center" rowspan="1" colspan="1">78.41 &#x000b1; 18.42</td><td align="center" rowspan="1" colspan="1">65.05 &#x000b1; 11.32<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">62.91 &#x000b1; 12.21<sup>#</sup>
</td><td align="center" rowspan="1" colspan="1">79.45 &#x000b1; 17.19</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MAP</td><td align="center" rowspan="1" colspan="1">93.05 &#x000b1; 10.98</td><td align="center" rowspan="1" colspan="1">81.59 &#x000b1; 17.37</td><td align="center" rowspan="1" colspan="1">77.23 &#x000b1; 16.09</td><td align="center" rowspan="1" colspan="1">88.32 &#x000b1; 13.98</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pH</td><td align="center" rowspan="1" colspan="1">7.37 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">7.32 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">7.33 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">7.38 &#x000b1; 0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pO<sub>2</sub>
</td><td align="center" rowspan="1" colspan="1">184.66 &#x000b1; 83.30</td><td align="center" rowspan="1" colspan="1">240.17 &#x000b1; 117.43</td><td align="center" rowspan="1" colspan="1">259.51 &#x000b1; 102.98</td><td align="center" rowspan="1" colspan="1">163.22 &#x000b1; 64.43</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;pCO<sub>2</sub>
</td><td align="center" rowspan="1" colspan="1">42.84 &#x000b1; 6.09</td><td align="center" rowspan="1" colspan="1">44.38 &#x000b1; 8.78</td><td align="center" rowspan="1" colspan="1">42.11 &#x000b1; 8.09</td><td align="center" rowspan="1" colspan="1">39.47 &#x000b1; 4.98</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>#</sup>
<italic>P</italic> &#x0003c; 0.05 when heart rate at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> in Group P was compared with that in Group S.</p></fn><fn><p>*<italic>P</italic> &#x0003c; 0.01 when pO<sub>2</sub> at <italic>t</italic>
<sub>2</sub> and <italic>t</italic>
<sub>3</sub> in Group S was compared with that in Group P.</p></fn></table-wrap-foot></table-wrap></floats-group></article>